A detailed history of Wells Fargo & Company transactions in Omega Therapeutics, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 23,440 shares of OMGA stock, worth $24,377. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,440
Previous 31,703 26.06%
Holding current value
$24,377
Previous $115,000 58.26%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$1.86 - $3.2 $15,369 - $26,441
-8,263 Reduced 26.06%
23,440 $48,000
Q1 2024

May 10, 2024

BUY
$2.73 - $5.32 $32,694 - $63,712
11,976 Added 60.71%
31,703 $115,000
Q4 2023

Feb 09, 2024

BUY
$1.35 - $3.21 $1,937 - $4,606
1,435 Added 7.84%
19,727 $59,000
Q3 2023

Nov 13, 2023

BUY
$2.15 - $5.68 $17,522 - $46,292
8,150 Added 80.36%
18,292 $39,000
Q2 2023

Aug 15, 2023

BUY
$5.6 - $9.66 $56,106 - $96,783
10,019 Added 8145.53%
10,142 $56,000
Q1 2023

May 12, 2023

BUY
$4.81 - $10.95 $9 - $21
2 Added 1.65%
123 $0
Q4 2022

Feb 13, 2023

BUY
$4.22 - $7.05 $12 - $21
3 Added 2.54%
121 $0
Q3 2022

Nov 14, 2022

BUY
$3.63 - $6.65 $243 - $445
67 Added 131.37%
118 $1,000
Q2 2022

Aug 12, 2022

SELL
$2.01 - $7.19 $28,694 - $102,644
-14,276 Reduced 99.64%
51 $0
Q1 2022

May 16, 2022

BUY
$6.24 - $14.04 $6,932 - $15,598
1,111 Added 8.41%
14,327 $89,000
Q4 2021

Feb 14, 2022

BUY
$11.33 - $29.38 $149,272 - $387,081
13,175 Added 32134.15%
13,216 $150,000
Q3 2021

Nov 15, 2021

BUY
$16.0 - $22.51 $656 - $922
41 New
41 $1,000

Others Institutions Holding OMGA

About Omega Therapeutics, Inc.


  • Ticker OMGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,853,400
  • Market Cap $49.8M
  • Description
  • Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...
More about OMGA
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.